Diabetes in pregnancy: are we providing the best care ... - HQIP
Diabetes in pregnancy: are we providing the best care ... - HQIP
Diabetes in pregnancy: are we providing the best care ... - HQIP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Table 6.5<br />
Association of specifi c preconception c<strong>are</strong> factors <strong>in</strong> women with type 1 and type 2 diabetes with poor <strong>pregnancy</strong><br />
outcome<br />
Preconception c<strong>are</strong> factor<br />
Cases<br />
n/N (%)<br />
Controls<br />
n/N (%)<br />
Crude OR<br />
[95% CI]<br />
Adjusted OR a<br />
[95% CI]<br />
No contraceptive advice provided<br />
before <strong>pregnancy</strong> 28/85 (33) 19/83 (23) 1.7 [0.8, 3.3] 1.7 [0.8, 3.5]<br />
No discussion of <strong>the</strong> follow<strong>in</strong>g<br />
specifi c diabetes issues:<br />
Alcohol <strong>in</strong>take 31/70 (44) 19/66 (29) 2.0 [1.0, 4.1] 2.5 [1.1, 5.4]<br />
Diet 20/103 (19) 12/100 (12) 1.8 [0.8, 3.9] 1.8 [0.8, 4.1]<br />
Poor glycaemic control 18/118 (15) 14/117 (12) 1.3 [0.6, 2.8] 1.2 [0.5, 2.5]<br />
Ret<strong>in</strong>opathy 25/83 (30) 25/96 (26) 1.2 [0.6, 2.4] 1.1 [0.6, 2.3]<br />
Nephropathy 28/74 (38) 29/76 (38) 1.0 [0.5, 1.9] 0.8 [0.4, 1.7]<br />
Hypertension 27/71 (38) 23/75 (31) 1.4 [0.7, 2.8] 1.1 [0.5, 2.3]<br />
No discussion of <strong>the</strong> follow<strong>in</strong>g <strong>pregnancy</strong> issues:<br />
Increased diabetes surveillance 13/123 (11) 7/124 (6) 2.0 [0.8, 5.2] 1.7 [0.6, 4.5]<br />
Increased <strong>pregnancy</strong> surveillance 13/117 (11) 8/124 (6) 1.8 [0.7, 4.6] 1.5 [0.6, 4.0]<br />
Increased risk of <strong>in</strong>duction 21/83 (25) 14/110 (13) 2.3 [1.1, 5.0] 2.2 [1.0, 4.9]<br />
Possible caes<strong>are</strong>an section 20/95 (21) 11/110 (10) 2.4 [1.1, 5.4] 2.4 [1.0, 5.8]<br />
Fetal risks <strong>in</strong> diabetic <strong>pregnancy</strong> 17/98 (17) 7/114 (6) 3.2 [1.3, 8.2] 2.9 [1.1, 8.2]<br />
No dietetic review 46/129 (36) 42/135 (61) 1.2 [0.7, 2.1] 1.2 [0.7, 2.1]<br />
No assessment of <strong>the</strong> follow<strong>in</strong>g diabetes<br />
complications <strong>in</strong> <strong>the</strong> 12 months prior to<br />
<strong>pregnancy</strong>:<br />
Basel<strong>in</strong>e ret<strong>in</strong>al exam<strong>in</strong>ation 36/141 (26) 18/137 (13) 2.3 [1.2, 4.3] 2.3 [1.2, 4.5]<br />
Basel<strong>in</strong>e test of renal function 26/130 (20) 15/133 (11) 2.0 [1.0, 3.9] 2.0 [0.9, 4.3]<br />
Assessment of album<strong>in</strong>uria 41/116 (35) 30/109 (28) 1.4 [0.8, 2.6] 1.5 [0.8, 2.8]<br />
Assessment of suboptimal preconception c<strong>are</strong><br />
(exclud<strong>in</strong>g glycaemic control) 116/133 (87) 80/134 (60) 4.6 [2.4, 8.8] 5.2 [2.7, 10.1]<br />
a<br />
adjusted for maternal age and deprivation.<br />
6.3.6 <strong>Diabetes</strong> c<strong>are</strong> (exclud<strong>in</strong>g glycaemic control)<br />
<strong>Diabetes</strong> c<strong>are</strong> <strong>in</strong> <strong>the</strong> enquiry referred to monitor<strong>in</strong>g for diabetes complications, <strong>in</strong>clud<strong>in</strong>g ret<strong>in</strong>al<br />
assessments and tests of renal function. F<strong>in</strong>d<strong>in</strong>gs <strong>are</strong> shown <strong>in</strong> table 6.6 and <strong>are</strong> discussed fur<strong>the</strong>r <strong>in</strong><br />
Chapter 9.<br />
29